The Impact of Bariatric Surgery on Comorbidities and Medication Use Among Obese Patients

Crémieux, Pierre-Yves; Ledoux, Severine; Clerici, Christine; Cremieux, Francois; Buessing, Marric
July 2010
Obesity Surgery;Jul2010, Vol. 20 Issue 7, p861
Academic Journal
The risks and benefits of bariatric surgery have rarely been evaluated in large multiyear patient samples. This study identifies the short- and long-term impact of bariatric surgery on comorbidities and medication use among obese patients. A comprehensive analysis of 5,502 obese patients who underwent bariatric surgery was performed. Submissions of reimbursement claims, including diagnostics and medication use, were compared in the 90 days preceding the surgery and 30 up to 1,110 days following the surgery. Presurgery and postsurgery frequency counts were performed on diagnostics and medication use to identify trends. Among 5,502 patients, significant decreases in the prevalence of reported comorbidities were observed during the short-term postsurgery period and sustained for up to 3 years of follow-up. Compared to the presurgery period, significant decreases ( p < 0.05) were observed after 3 years for total cardiovascular disorders (43.6% vs. 14.2%), diabetes mellitus (19.9% vs. 7.7%), chronic obstructive pulmonary disease and other respiratory conditions (57.7% vs. 16.2%), diseases of the musculoskeletal system and connective tissue (32.6% vs. 27.7%), and mental disorders (30.7% vs. 14.8%). Over the same period, the frequency of medication use decreased significantly for a number of conditions including infections, pain, respiratory, cardiovascular, gastroenterologic, lipidemic, and diabetic conditions. Anemia, however, increased from 3.8% to 9.9%, and use of nutritional supplements increased significantly. Bariatric surgery was associated with significant reductions in reported claims for short- and long-term health outcomes and reduced medication use for major disease categories.


Related Articles

  • Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass. Prachand, Vivek N.; Ward, Marc; Alverdy, John C. // Journal of Gastrointestinal Surgery;Feb2010, Vol. 14 Issue 2, p211 

    Objective: Increased body mass index is associated with greater incidence and severity of obesity-related comorbidities and inadequate postbariatric surgery weight loss. Accordingly, comorbidity resolution is an important measure of surgical outcome in super-obese individuals. We...

  • HOPE FOR THE morbidly obese. Bock-Lopez, Michele; Bauer, Jeff // RN;Dec2001, Vol. 64 Issue 12, p56 

    Focuses on the conduction of bariatic surgery on obese persons in the United States. Association of cardiovascular disease on the condition; Option for having a low-calorie diet as a treatment; Medical operations to be undergone by patients pursuing the surgery. INSET: How bariatric surgery is...

  • Key Global Literature. Pendergrass, Merri // Diabetes Care;May2007, Vol. 30 Issue 5, p1327 

    The article presents information on several studies performed on diabetes patients. It states that a retrospective, longitudinal, intergroup analysis was performed on morbidly obese diabetic patients who had bariatric surgery between December 2001 and December 2005. It says that eleven male type...

  • Prevalence of Endocrine Diseases in Morbidly Obese Patients Scheduled for Bariatric Surgery: Beyond Diabetes. Fierabracci, Paola; Pinchera, Aldo; Martinelli, Silvia; Scartabelli, Giovanna; Salvetti, Guido; Giannetti, Monica; Pucci, Andrea; Galli, Giulia; Ricco, Ilaria; Querci, Giorgia; Rago, Teresa; Di Salvo, Claudio; Anselmino, Marco; Vitti, Paolo; Santini, Ferruccio // Obesity Surgery;Jan2011, Vol. 21 Issue 1, p54 

    Background: Bariatric surgery allows stable body weight reduction in morbidly obese patients. In presurgical evaluation, obesity-related co-morbidities must be considered, and a multidisciplinary approach is recommended. Precise guidelines concerning the endocrinological evaluation to be...

  • Bariatric Surgery: Cost-Effectiveness and Budget Impact. Terranova, Lorenzo; Busetto, Luca; Vestri, Annarita; Zappa, Marco // Obesity Surgery;Apr2012, Vol. 22 Issue 4, p646 

    Bariatric surgery is to date the most effective treatment for morbid obesity and it has been proven to reduce obesity-related comorbidities and total mortality. As any medical treatment, bariatric surgery is costly and doubts about its affordability have been raised. On the other hand, bariatric...

  • Barriers in the Approach of Obese Patients Undergoing Bariatric Surgery in Flemish Hospitals. Gesquiere, Ina; Augustijns, Patrick; Lannoo, Matthias; Matthys, Christophe; Schueren, Bart; Foulon, Veerle // Obesity Surgery;Nov2015, Vol. 25 Issue 11, p2153 

    Background: Bariatric surgery is associated not only with weight loss and improvement of comorbidities of obesity but also with short and long-term complications. Preoperative screening and lifelong follow-up of these patients are important to optimize the effect of bariatric surgery and...

  • Bariatric Surgery May Improve and Reverse Diabetes.  // Heart Advisor;Jun2012, Vol. 15 Issue 6, p5 

    The article focuses on a study conducted by the researchers in Cleveland Clinic, Ohio headed by Dr. Philip Schauer that explores the importance of bariatric surgery. It notes that the study involved 150 patients with obesity and poorly controlled diabetes. Results highlight the representation of...

  • Bariatric surgery for obese diabetic subjects.  // OB/GYN Clinical Alert;Jul2009 Clinical Briefs in Primary, p14 

    The article presents a study that compares surgical therapy with conventional diabetes management for obese diabetic patients in Australia. The study shows that costs for surgical group were 7-fold greater than conventional treatment and difference of costs declined with time. It reveals that...

  • Gastric Bypass Surgery Being Considered as Treatment for Type 2.  // Diabetes Health;Aug/Sep2007, Vol. 17 Issue 4, p24 

    The article reveals that bariatric surgery which was formerly used for treating obesity, is being explored as a cure for type 2 diabetes in normal weight or moderately overweight people. Research showed that 84 percent of patients who underwent Roux-en-Y gastric bypass (RYGB) experienced...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics